Abstract:Objective. A rare case of myeloid sarcoma (MS), previously referred to as granulocytic sarcoma or chloroma, is presented. Representing a unique form of acute myeloid leukemia (AML), MS may rarely occur in adults. Even rarer, MS may occur as the initial presentation of AML. Methods. We report a singular and illustrative case of an orbital pseudotumor mimicking mass in a 65-year-old male as the initial presentation of AML. Results. Neurosurgical intervention was required to establish the definitive diagnosis via… Show more
“…Myeloid sarcoma (MS) was previously referred to as granulocytic sarcoma and also by the name chloroma meaning 'green tumor' [3] .King in 1853 coined the term chloroma due to its frequent green color [4].This macroscopic green appearance is caused by the production of myeloperoxidase in many of these tumors [3]. MS is a tumoral mass of either myeloblasts or immature myeloid cells in extramedullary sites.…”
Section: Discussionmentioning
confidence: 99%
“…Diagnosing myeloid sarcoma of the head and neck region poses a big challenge, because of the low frequency of occurrence and the potential for almost any lineage of tumour to occur in this region. MS can be mistaken on histology for non-Hodgkin's lymphoma, small round cell tumors such as neuroblastoma or undifferentiated carcinoma [4]. As such, a high degree of suspicion is needed when dealing with a probable case of myeloid sarcoma [5].…”
Section: Discussionmentioning
confidence: 99%
“…MS can be the initial presentation of acute myeloid leukemia or it can arise de-novo; on its own [3]. MS usually occurs in the pediatric population, and rarely occurs in adults [4]. Besides simple blood parameters, MS of head and neck region requires the aid of immunohistochemical staining as a definite diagnostic tool [5].…”
Myeloid sarcoma is a rare disease, where a mass (tumour) of either myeloblasts or immature myeloid cells conglomerate in extramedullary anatomic sites. It may arise de-novo or it may present in association with acute myeloid leukemia. It can also occur in patients with myelodysplastic syndromes, myeloproliferative disorders, and as blast transformation in myeloproliferative neoplasia. Myeloid sarcoma of the head and neck area can pose a diagnostic challenge because of the low frequency of occurrence, and the vast diversity of tumours occurring from multiple lineages in this anatomic region. This can lead to a broad spectrum of various differential diagnoses. Therefore, a high index of suspicion is required when dealing with a possible case of myeloid sarcoma, as it is a time sensitive diagnosis with various diagnostic dilemmas. Here, we report an example, a case of tonsillar myeloid sarcoma. We wish to highlight the investigations that helped us procure this diagnosis in a timely manner.
“…Myeloid sarcoma (MS) was previously referred to as granulocytic sarcoma and also by the name chloroma meaning 'green tumor' [3] .King in 1853 coined the term chloroma due to its frequent green color [4].This macroscopic green appearance is caused by the production of myeloperoxidase in many of these tumors [3]. MS is a tumoral mass of either myeloblasts or immature myeloid cells in extramedullary sites.…”
Section: Discussionmentioning
confidence: 99%
“…Diagnosing myeloid sarcoma of the head and neck region poses a big challenge, because of the low frequency of occurrence and the potential for almost any lineage of tumour to occur in this region. MS can be mistaken on histology for non-Hodgkin's lymphoma, small round cell tumors such as neuroblastoma or undifferentiated carcinoma [4]. As such, a high degree of suspicion is needed when dealing with a probable case of myeloid sarcoma [5].…”
Section: Discussionmentioning
confidence: 99%
“…MS can be the initial presentation of acute myeloid leukemia or it can arise de-novo; on its own [3]. MS usually occurs in the pediatric population, and rarely occurs in adults [4]. Besides simple blood parameters, MS of head and neck region requires the aid of immunohistochemical staining as a definite diagnostic tool [5].…”
Myeloid sarcoma is a rare disease, where a mass (tumour) of either myeloblasts or immature myeloid cells conglomerate in extramedullary anatomic sites. It may arise de-novo or it may present in association with acute myeloid leukemia. It can also occur in patients with myelodysplastic syndromes, myeloproliferative disorders, and as blast transformation in myeloproliferative neoplasia. Myeloid sarcoma of the head and neck area can pose a diagnostic challenge because of the low frequency of occurrence, and the vast diversity of tumours occurring from multiple lineages in this anatomic region. This can lead to a broad spectrum of various differential diagnoses. Therefore, a high index of suspicion is required when dealing with a possible case of myeloid sarcoma, as it is a time sensitive diagnosis with various diagnostic dilemmas. Here, we report an example, a case of tonsillar myeloid sarcoma. We wish to highlight the investigations that helped us procure this diagnosis in a timely manner.
“…Orbital granulocytic sarcoma occurs more commonly in paediatric rather than adult AML. Rapid visual loss from orbitopathy leading to compression of the optic nerve is an oncological emergency 3. Decompressive surgery and radiation have both been used successfully.…”
“…MS can occur in diverse clinical presentations including; (Christopher, William, & Bonnie, Seong-Jin, Farahvar, Chen, & Wang, 2014;Dock, 1983). a) Initial presentation in a healthy individual in whom a typical AML with leukaemic phase evolves after an interval of weeks, months or years b) The first manifestation of relapse in a patient previously treated for leukaemia c) Patients in the active phase of AML MS occurs in all age groups with some reports showing a median age of 56 years and a wide range of 1 month to 89 years (Falini et al, 2007;Piled et al, 2007;Neiman, Barcos, Berard, Bonner, Mann, Rydell, & Bennett, 1981;Goyal et al, 2017).…”
Objective: Myeloid sarcoma is a rare form of acute myeloid leukaemia characterized by extramedullary proliferation of myeloid blasts which can occur as an isolated lesion in any organ. Even rarer it may occur in the orbit as the initial presentation without a leukaemic phase and diagnosis may be challenging when it is not suspected.
Methods:We report a case of orbital myeloid sarcoma as the initial presentation of acute myeloid leukaemia in an adult who was misdiagnosed and treated as a case of a pseudotumour with resultant significant disease progression and worsening of the clinical condition. There was a lag of four months from the onset of eye mass to the development of acute myeloid leukaemia.Result: Due to patients worsening condition and tumour progression, a repeat biopsy for a second histology opinion at a different facility, immunophenotyping and immunohistochemistry were employed to arrive at the correct diagnosis. Following chemotherapy, the orbital mass reduced markedly and clinical condition improved. The patient was indigent and could not sustain further funding of his treatment because he had already spent much on for management of complications he developed before a definitive diagnosis could be made.
Conclusion:Myeloid sarcoma can present as an orbital mass without a leukemic disease. Therefore a high index of suspicion, meticulous examination of biopsy, immunohistochemistry and collaboration between oncologists and ophthalmologists, are required to arrive at an early accurate diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.